How to use Technology Searches
The `Technologies Searched´-section displays profiles of unmet needs covering a broad spectrum from scientific expertise to clinical stage product candidates. Text search allows the use of phrases not yet part of our category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in `Sector´, "Cancerous, neoplasmatic" in `Disease Category, "Drugs, Small Molecule" in `Technology´ and "Preclinical" in `Development Stage. Selection of "Enabling Technology, Platform technology" in `Sector´ will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee. Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Summary
Kissei is seeking collaborations
Organization name
Kissei Pharmaceutical business development
Profile
Kissei Pharmaceutical Co., Ltd. believes that R&D is fundamental to the operations of a pharmaceutical company, and that belief forms the foundation of their aggressive approach to R&D.
In addition to their commitment to being an R&D-oriented pharmaceutical company that provides high-quality, innovative pharmaceutical products, they actively seek licensing opportunities to tie up with other pharmaceutical companies and bio-ventures around the world.
Through such collaborative arrangements, they offer various innovative medicines that are clinically used in the treatment of many patients, including Bezatol®, an agent for hyperlipidemia (licensed from Roche); Cabasar®, an agent for Parkinson's disease (licensed from Pfizer).
Based on their licensing policy, they are widely accepting new ideas and technologies for the development of new medicines. You are invited to submit a non-confidential scientific overview of your ideas or technologies for their scientific review by submitting an offer online.
Their R&D activities focus on the
- urogenital system
- metabolism and endocrinology
- immunology and allergies.
URL
http://www.kissei.co.jp/e_contents/idea/idea_e.htmlYour feedback
back
print this page
